Affitech Renews Exclusive Worldwide Phage Display License From DKFZ

Chicago, April 9, 2006 - The human antibody company, Affitech AS, announced today at BIO 2006 that they have renewed an exclusive worldwide licensing agreement with DKFZ (German Cancer Research Center) of Heidelberg, Germany for the antibody library display patents, otherwise known as “Breitling” IP family.

Source: Affitech